Can angiotensin receptor blockers (ARBs) prevent Parkinson disease in patients with hypertension? New research looks at the role of ARBs in reducing oxidative stress, and therefore, potentially lowering the risk for Parkinson disease. In this video, Joseph S. Aplert, MD, editor-in chief of the American Journal of Medicine, discusses “Association of Angiotensin Receptor Blockers with Incident Parkinson Disease in Patients with Hypertension: A Retrospective Cohort Study” by Lin et al. It is in the August 2022 issue of The American Journal of Medicine, available on our website at amjmed.com.
Can ARBs Prevent Parkinson Disease in Patients with Hypertension? (video)
Latest Posts
Sarcoidosis with Lupus Pernio in an Afro-Caribbean Man
A 54-year-old man of Afro-Caribbean ancestry presented with a 2-month history of nonproductive cough, 10-day history of constant subjective fevers, and a 1-day history...
Flu Vaccination to Prevent Cardiovascular Mortality (video)
"Influenza can cause a significant burden on patients with coronary artery disease," write Barbetta et al in The American Journal of Medicine. For this...
Varicella Zoster Virus-Induced Complete Heart Block
Complete heart block is usually caused by chronic myocardial ischemia and fibrosis but can also be induced by bacterial and viral infections. The varicella...
Teaching Anti-Racism in the Clinical Environment
"Teaching Anti-Racism in the Clinical Environment: The Five-Minute Moment for Racial Justice in Healthcare" was originally published in the April 2023 issue of The...
The ‘Invisible Hand’ Doesn’t Work for Prescription Drugs
Pharmaceutical innovation has been responsible for many “miracles of modern medicine.” Reliance on the “invisible hand” of Adam Smith to allocate resources in the...
New Coronary Heart Disease Risk Factors
"New Coronary Heart Disease Risk Factors" by AJM Editor-in Chief Joseph S. Alpert, MD was originally published in the April 2023 issue of The...
Cardiac Risk Related to Noncardiac & Nonsurgical Activities
"Assessment of Cardiovascular Risk for Noncardiac and Nonsurgical Activities" was originally published in the April 2023 issue of The American Journal of Medicine.
Cardiovascular risk...
